Measuring the Pace of New Drug Development in the User Fee ERA
- 1 July 2000
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 34 (3) , 673-680
- https://doi.org/10.1177/009286150003400303
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee EraDrug Information Journal, 2000
- Initiatives to Speed New Drug Development and Regulatory Review: The Impact of FDA-Sponsor ConferencesDrug Information Journal, 1997
- THE PRESCRIPTION DRUG USER FEE ACT OF 1992 AND THE NEW DRUG DEVELOPMENT PROCESSClinical Journal of Sport Medicine, 1997
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991